345 related articles for article (PubMed ID: 22811449)
1. Clinical experience with three-factor prothrombin complex concentrate to reverse warfarin anticoagulation in intracranial hemorrhage.
Switzer JA; Rocker J; Mohorn P; Waller JL; Hughes D; Bruno A; Nichols FT; Hess DC; Natarajan K; Fagan SC
Stroke; 2012 Sep; 43(9):2500-2. PubMed ID: 22811449
[TBL] [Abstract][Full Text] [Related]
2. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
[TBL] [Abstract][Full Text] [Related]
3. Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.
Woo CH; Patel N; Conell C; Rao VA; Faigeles BS; Patel MC; Pombra J; Akins PT; Axelrod YK; Ge IY; Sheridan WF; Flint AC
World Neurosurg; 2014 Jan; 81(1):110-5. PubMed ID: 23220122
[TBL] [Abstract][Full Text] [Related]
4. Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin.
Chapman SA; Irwin ED; Beal AL; Kulinski NM; Hutson KE; Thorson MA
Ann Pharmacother; 2011 Jul; 45(7-8):869-75. PubMed ID: 21775690
[TBL] [Abstract][Full Text] [Related]
5. Rapid reversal of coagulopathy in warfarin-related intracranial haemorrhages with prothrombin complex concentrates.
Chong CT; Lew TW; Kuperan P; Tan JJ; Tan HL; Kwek TK
Anaesth Intensive Care; 2010 May; 38(3):474-80. PubMed ID: 20514955
[TBL] [Abstract][Full Text] [Related]
6. Prothrombin complex concentrate accelerates international normalized ratio reversal and diminishes the extension of intracranial hemorrhage in geriatric trauma patients.
Edavettal M; Rogers A; Rogers F; Horst M; Leng W
Am Surg; 2014 Apr; 80(4):372-6. PubMed ID: 24887668
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical Center.
Al-Majzoub O; Rybak E; Reardon DP; Krause P; Connors JM
J Emerg Med; 2016 Jan; 50(1):7-13. PubMed ID: 26433428
[TBL] [Abstract][Full Text] [Related]
8. Reversal of warfarin associated coagulopathy with 4-factor prothrombin complex concentrate in traumatic brain injury and intracranial hemorrhage.
Yanamadala V; Walcott BP; Fecci PE; Rozman P; Kumar JI; Nahed BV; Swearingen B
J Clin Neurosci; 2014 Nov; 21(11):1881-4. PubMed ID: 24953825
[TBL] [Abstract][Full Text] [Related]
9. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
Le Roux P; Pollack CV; Milan M; Schaefer A
J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
[TBL] [Abstract][Full Text] [Related]
10. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose.
Holland L; Warkentin TE; Refaai M; Crowther MA; Johnston MA; Sarode R
Transfusion; 2009 Jun; 49(6):1171-7. PubMed ID: 19210325
[TBL] [Abstract][Full Text] [Related]
11. Experiences with an activated 4-factor prothrombin complex concentrate (FEIBA) for reversal of warfarin-related bleeding.
Stewart WS; Pettit H
Am J Emerg Med; 2013 Aug; 31(8):1251-4. PubMed ID: 23763937
[TBL] [Abstract][Full Text] [Related]
12. Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Bleeding in Neurosurgical Patients: A Single-Center Experience.
Mačiukaitienė J; Bilskienė D; Tamašauskas A; Bunevičius A
Medicina (Kaunas); 2018 Apr; 54(2):. PubMed ID: 30344253
[No Abstract] [Full Text] [Related]
13. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
Yasaka M; Sakata T; Naritomi H; Minematsu K
Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
[TBL] [Abstract][Full Text] [Related]
14. Effect of prothrombin complex concentrate on hematoma enlargement and clinical outcome in patients with anticoagulant-associated intracerebral hemorrhage.
Kuwashiro T; Yasaka M; Itabashi R; Nakagaki H; Miyashita F; Naritomi H; Minematsu K
Cerebrovasc Dis; 2011; 31(2):170-6. PubMed ID: 21135553
[TBL] [Abstract][Full Text] [Related]
15. Optimizing the dose of three-factor prothrombin complex concentrate in traumatic brain injury patients on warfarin therapy.
Huynh TK; Costello JL; Rebuck JA
Pharmacotherapy; 2014 Mar; 34(3):260-4. PubMed ID: 24338807
[TBL] [Abstract][Full Text] [Related]
16. Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0.
Zemrak WR; Smith KE; Rolfe SS; May T; Trowbridge RL; Hayes TL; Grindlinger GA; Seder DB
Neurocrit Care; 2017 Dec; 27(3):334-340. PubMed ID: 28660341
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the safety and efficacy between 3-factor and 4-factor prothrombin complex concentrates for the reversal of warfarin.
Kuroski JE; Young S
Am J Emerg Med; 2017 Jun; 35(6):871-874. PubMed ID: 28161220
[TBL] [Abstract][Full Text] [Related]
18. Reversal of coagulopathy using prothrombin complex concentrates is associated with improved outcome compared to fresh frozen plasma in warfarin-associated intracranial hemorrhage.
Frontera JA; Gordon E; Zach V; Jovine M; Uchino K; Hussain MS; Aledort L
Neurocrit Care; 2014 Dec; 21(3):397-406. PubMed ID: 24671832
[TBL] [Abstract][Full Text] [Related]
19. Obesity increases risk of anticoagulation reversal failure with prothrombin complex concentrate in those with intracranial hemorrhage.
Chu C; Tokumaru S; Izumi K; Nakagawa K
Int J Neurosci; 2016; 126(1):62-6. PubMed ID: 25430740
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation.
Endres K; St Bernard R; Chin-Yee I; Hsia C; Lazo-Langner A
Hematology; 2020 Dec; 25(1):489-493. PubMed ID: 33317427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
